| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149448 Phenoxyacetic Acid Derivatives Useful for Treating Respiratory Diseases |
| 06/11/2009 | CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | CA2706610A1 Sulfur containing fluoroalkyl amines and isocyanates |
| 06/10/2009 | EP2067771A1 Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds |
| 06/10/2009 | EP2066642A1 Soluble epoxide hydrolase inhibitors |
| 06/10/2009 | EP2066627A1 Novel minor groove binders |
| 06/10/2009 | EP1858866B1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
| 06/10/2009 | EP1732971A4 Process for the preparation of activated polyethylene glycols |
| 06/10/2009 | EP1135122B1 Use of amtolmetin guacyl as for the treatment of intestinal inflammations |
| 06/10/2009 | CN101454282A Method for preparing mercaptoheterocycle compound |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN101450924A 3-3'-substituted 2,2'-dipyrrolidine compounds and salts thereof |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/09/2009 | US7544814 lactam fermentation products; pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane; based on marine microorganisms structures; cytotoxicity, NF- kappa B inhibition, and caspase-like and trypsin-like proteasome inhibition |
| 06/09/2009 | US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/09/2009 | US7544714 Lipid-amino acid conjugates and methods of use |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544686 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof |
| 06/09/2009 | US7544667 Hypocholesterolemic compounds |
| 06/09/2009 | CA2481005C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009067797A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
| 06/04/2009 | US20090143459 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/04/2009 | US20090143397 Catechol-based derivatives for treating or preventing diabetics |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
| 06/03/2009 | EP2065368A1 Inhibitors of IAP |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | CN101448786A Method of preparation and use of pharmacologically active N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidinone |
| 06/03/2009 | CN101448785A Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 06/03/2009 | CN101445477A Method for preparing N-substituted maleimide type |
| 06/03/2009 | CN101445476A Chemosynthesis method for Alpha-ethyl-2-oxo-1-methyl pyrrolidineacetate |
| 06/03/2009 | CN101445475A Method for preparing (trans)-4-cyclohexyl-L-proline |
| 06/03/2009 | CN100494203C Functionalized ionic liquids, and methods of use thereof |
| 06/02/2009 | US7541377 1-[2-(Aminomethyl)phenyl]-N-[2-methyl-6-[[(1-methylethyl)amino]carbonyl]phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide; pesticides |
| 06/02/2009 | US7541374 Malononitrile compounds and use thereof |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | CA2410160C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 06/02/2009 | CA2392025C Process for the preparation of amorphous atorvastatin |
| 06/02/2009 | CA2116421C Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors |
| 05/28/2009 | WO2009067621A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009067491A2 Derivatized tertiary amines and uses thereof |
| 05/28/2009 | WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
| 05/28/2009 | US20090138208 Immunoglobulin g binding pocket |
| 05/28/2009 | US20090137819 Method of Producing Optically Active 4-Amino-3-Substituted Phenylbutanoic Acid |
| 05/28/2009 | US20090137800 Novel compound, optical filter and optical recording material using the same |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137495 Organic Compounds and Their Uses |
| 05/28/2009 | US20090136474 Stabilized Protease Composition |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | CA2703893A1 Compound |
| 05/27/2009 | EP2061779A1 Aryl sulfonamides with an analgesic action |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP2061756A2 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants |
| 05/27/2009 | EP1749002B1 Pyrrole or imidazole amides for treating obesity |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443310A Process for continuously preparing n- ethyl-2-pyrrolidone (NEP) |
| 05/27/2009 | CN101443309A IAP BIR domain binding compounds |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/26/2009 | US7538245 Process for the manufacture of an enantiopure compound |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538231 Tyrosine kinase inhibitors |
| 05/26/2009 | US7538228 Transition metal complexes of ligands, e.g., oxzolines, bis-oxazolines, phosphine oxazolines and analgous thiazolines, imidazolines, pyrazolines; conformational rigidity for high enantioselectivity using bidentate ligands; catalyzed reactions include hydrogenation, hydrosilation, hydroboration and others |
| 05/26/2009 | US7538136 Crystalline forms of atorvastatin |
| 05/26/2009 | US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009063476A1 A crystalline form of atorvastatin hemi magnesium salt and a process thereof |
| 05/22/2009 | WO2009062371A1 Carbamate derivatives, and the use as medicament |
| 05/22/2009 | WO2009040755A3 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/21/2009 | US20090131938 polysuccinimide monomer copolymerized with albumin or polylysine or a PEG-amine in situ; use after surgery, for internally to seal the wound site and prevent fluid leakage; biocompatibility; biodegrade over time into degradation products that are water soluble |
| 05/21/2009 | US20090131683 Process for the preparation of atorvastatin and intermediates |
| 05/21/2009 | US20090131433 such as 3-(3-Acetyl-phenyl)-1-[3-(3-chloro-4-pyrrolidin-1-ylmethyl-phenoxy)-cyclobutylmethyl]-1-methyl-urea, used for the treatment of , schizophrenia, Alzheimer's disease, attention-deficit hyperactivity disorder, hypotension, allergies, cardiovascular, gastrointestinal and psychological disorders |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090130487 Compounds for placing objects by self assembling and the use thereof |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2059504A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors |
| 05/20/2009 | EP2059502A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | CN101437809A Glycosidase inhibitors and methods of synthesizing same |
| 05/20/2009 | CN101437791A Crystalline form of atorvastatin calcium stable after storage |
| 05/20/2009 | CN101437511A Agent for preventing liver disease |
| 05/20/2009 | CN101434570A Pyrrolidine derivative, and preparation and use thereof |
| 05/19/2009 | US7534882 Method for preparing pyrrolotriazine compounds via in situ amination of pyrroles |
| 05/19/2009 | US7534881 Method for preparing pyrrolotriazine compounds |
| 05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
| 05/19/2009 | US7534810 Crystalline form of atorvastatin sodium or its hydrate; use treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534751 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 05/19/2009 | CA2521923C Substance exhibiting antidepressant property |
| 05/19/2009 | CA2468879C Substituted cyclohexane derivatives |